UCL Institute of Neurology

A drug used to treat patients with diabetes could benefit people with Parkinson’s Disease, according to research led by UCL Institute of Neurology.

Much of the dramatic change in the outlook for many stroke patients has come about as a result of carefully conducted clinical trials testing new treatments, says Martin Brown, Professor of Stroke Medicine at the UCL Institute of Neurology, in an article in the latest Raconteur report “Understanding Stroke”.

Researchers at the UCL Institute of Neurology together with international collaborators have identified a new gene, BICD2, which causes both dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraparesis.

The Education Unit would like to highlight the following teaching awards

Clinical Teaching Awards

An international team led by researchers at the UCL Institute of Neurology has identified a set of tests that could help identify whether - and how - Huntington’s disease (HD) is progressing in groups of people who are not yet showing symptoms.